Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$526.03M
Total Bought:
$154.97M
Total Sold:
$95.23M
Net Transaction:
+$59.74M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société Anonyme(ABVX)600,747516,447-84,300$66.89M$68.82M13.08%+$1.93M
Insmed Incorporated(INSM)628,712589,052-39,660$102.81M$62.80M11.94%-$40.00M
Trevi Therapeutics, Inc.(TRVI)2,013,6022,210,852+197,250$24.02M$41.23M7.84%+$17.21M
BrightSpring Health Services, Inc.(BTSG)53,800517,315+463,515$2.29M$36.08M6.86%+$33.79M
Revolution Medicines, Inc.(RVMD)124,990185,390+60,400$12.16M$34.72M6.60%+$22.56M
argenx SE(ARGX)29,73929,7390$21.72M$27.59M5.25%+$5.87M
Alkermes plc(ALKS)0448,964+448,964$0$23.52M4.47%+$23.52M
Travere Therapeutics, Inc.(TVTX)70,700339,033+268,333$2.10M$19.26M3.66%+$17.16M
AstraZeneca PLC(AZN)95,37698,376+3,000$18.81M$18.65M3.55%-$156.0K
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
503,936503,9360$16.13M$17.08M3.25%+$947.4K
Dianthus Therapeutics, Inc.(DNTH)162,990162,9900$13.68M$15.89M3.02%+$2.21M
Quest Diagnostics Incorporated(DGX)40,81765,122+24,305$8.00M$13.80M2.62%+$5.80M
Ionis Pharmaceuticals, Inc.(IONS)144,376144,3760$10.84M$11.45M2.18%+$606.4K
EYEPOINT INC767,098767,0980$9.89M$10.97M2.09%+$1.08M
ALUMIS INC325,046278,546-46,500$7.16M$7.84M1.49%+$677.5K
Viking Therapeutics, Inc.(VKTX)180,731180,7310$5.88M$7.05M1.34%+$1.17M
Celcuity Inc.(CELC)15,57659,316+43,740$1.78M$6.21M1.18%+$4.43M
Cytokinetics, Incorporated(CYTK)16,30070,700+54,400$1.07M$6.02M1.14%+$4.95M
Merck & Co., Inc.(MRK)46,70046,7000$5.62M$6.00M1.14%+$383.4K
Rapport Therapeutics, Inc.(RAPP)138,508138,5080$4.33M$5.77M1.10%+$1.44M
Johnson & Johnson(JNJ)22,60022,6000$5.52M$5.74M1.09%+$215.4K
Guardant Health, Inc.(GH)038,100+38,100$0$5.72M1.09%+$5.72M
ABSCI CORPORATION0464,444+464,444$0$5.38M1.02%+$5.38M
Scholar Rock Holding Corporation(SRRK)96,28596,2850$4.73M$5.30M1.01%+$562.3K
SIONNA THERAPEUTICS INC119,741119,7410$4.80M$5.27M1.00%+$467.0K
Ascendis Pharma A/S(ASND)017,740+17,740$0$4.73M0.90%+$4.73M
Roivant Sciences Ltd.(ROIV)129,800129,8000$3.60M$4.59M0.87%+$998.2K
PALISADE BIO INC1,992,3671,992,3670$3.49M$4.16M0.79%+$677.4K
Edgewise Therapeutics, Inc.(EWTX)65,50098,800+33,300$2.06M$4.01M0.76%+$1.95M
Biogen Inc.(BIIB)18,43718,4370$3.38M$3.98M0.76%+$603.4K
Xenon Pharmaceuticals Inc.(XENE)65,00065,0000$3.78M$3.92M0.75%+$143.7K
Belite Bio, Inc(BLTE)24,98924,9890$3.98M$3.85M0.73%-$136.3K
Mineralys Therapeutics, Inc.(MLYS)137,800137,8000$3.73M$3.72M0.71%-$15.2K
PROKIDNEY CORP1,806,9391,806,9390$3.23M$3.69M0.70%+$451.7K
ENLIVEN THERAPEUTICS INC20,90072,100+51,200$819.3K$3.66M0.70%+$2.84M
Oruka Therapeutics, Inc.(ORKA)033,400+33,400$0$3.18M0.60%+$3.18M
PROTAGONIST THERAPEUTICS INC22,93122,951+20$2.42M$2.81M0.53%+$396.4K
United Therapeutics Corporation(UTHR)5,0005,0000$2.96M$2.71M0.52%-$255.8K
BRIGHT MINDS BIOSCIENCES INC38,40738,4070$2.80M$2.70M0.51%-$106.4K
Kiniksa Pharmaceuticals International, plc(KNSA)29,20029,2000$1.41M$1.87M0.35%+$461.4K
COMPASS THERAPEUTICS INC0383,200+383,200$0$839.2K0.16%+$839.2K
Praxis Precision Medicines, Inc.(PRAX)2,5002,5000$805.5K$837.0K0.16%+$31.5K
Kodiak Sciences Inc.(KOD)17,01917,0190$648.8K$663.1K0.13%+$14.3K
TENAX THERAPEUTICS INC42,08042,0800$672.9K$612.3K0.12%-$60.6K
NUVALENT INC4,9004,9000$502.0K$605.1K0.12%+$103.1K
PEPGEN INC205,324205,3240$363.4K$369.6K0.07%+$6.2K
Spyre Therapeutics, Inc.(SYRE)04,000+4,000$0$355.1K0.07%+$355.1K
AbbVie Inc.(ABBV)14,5000-14,500$3.15M$0—-$3.15M
APOGEE THERAPEUTICS INC5,8860-5,886$495.4K$0—-$495.4K
Ascendis Pharma A/S(ASND)17,7400-17,740$4.06M$0—-$4.06M
AVALO THERAPEUTICS INC28,9700-28,970$432.5K$0—-$432.5K
BridgeBio Pharma, Inc.(BBIO)20,4000-20,400$1.51M$0—-$1.51M
Eli Lilly and Company(LLY)38,2200-38,220$35.15M$0—-$35.15M
SOLENO THERAPEUTICS INC68,4900-68,490$2.29M$0—-$2.29M
TERNS PHARMACEUTICALS INC104,8000-104,800$5.53M$0—-$5.53M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q2 2026 | TickerTrail